Ikena Oncology Inc (NASDAQ:IKNA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IKNA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IKNA

  • Market Cap$577.160m
  • SymbolNASDAQ:IKNA
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS45175G1085

Company Profile

Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. The company is advancing five clinical, preclinical and discovery programs: IK-007, an EP4 receptor antagonist; IK-175, an AHR antagonist; IK-412, a kynurenine-degrading enzyme Kynase; discovery-stage molecules targeting the Hippo signaling pathway; and a discovery-stage program against an undisclosed target.

Latest IKNA news

Currently there for this company. Visit our news hub for other news .